GlassScriptPhysician profile
Carin Rojas
NPI 1891187662
$4,588.86
in general payments reported to CMS, 2019-2025
15 companies · $2,490 in 2025
The $2,490 reported for 2025 was more than what 90% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $117 · 2022: $14.76 · 2024: $1,967 · 2025: $2,490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,022 · Travel and Lodging: $435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,022.44 |
| Travel and Lodging | $434.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,714.29 | 2020-2025 | Clareon, Clareon Panoptix Pro, Rocklatan |
| New World Medical,INC. | $924.73 | 2025 | Via360, Kahook Dual Blade, Ahmed Glaucoma Valve |
| Biotissue Holdings INC. | $494.35 | 2022-2025 | |
| Abbvie INC. | $438.13 | 2024-2025 | |
| Sight Sciences, INC. | $311.59 | 2024-2025 | Omni Surgical System |
| Johnson & Johnson Surgical Vision, INC. | $211.40 | 2024 | Tecnis Simplicity, Catalys System |
| Genentech, INC. | $121.74 | 2025 | Vabysmo |
| Oyster Point Pharma, INC. | $72.76 | 2024-2025 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $70.31 | 2024-2025 | Xdemvy |
| Glaukos Corporation | $68.71 | 2025 | Idosetr |
| Rxsight INC | $65.29 | 2024-2025 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Harrow Eye, LLC | $28.22 | 2025 | Vevye |
| Dompe US, INC. | $24.09 | 2024 | Oxervate |
| Thea Pharma INC. | $21.96 | 2024 | Iyuzeh |
| Amgen INC. | $21.29 | 2025 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carin Rojas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.